By Shutting Down Inflammation, Agent Reverses Damage From Spinal Cord Injury In Preclinical Studies

Researchers at Georgetown University Medical Center (GUMC) have been able to speed recovery and substantially reduce damage resulting from spinal cord injury in preclinical studies. Their research, published online in Annals of Neurology and led by Kimberly Byrnes, PhD, shows that inflammation following injury causes the neurotoxicity that leads to lasting nerve cell damage, and that an experimental agent is able to block this inflammatory reaction.

More: continued here

Filed under: Clinical Trials on April 3rd, 2009